The growing demand for orthopedic implants, driven by an aging global population and the rising occurrence of bone abnormalities and defects, relies heavily on biocompatible titanium (Ti) and its alloys. However, their inherent biological inertness often results in poor osseointegration and increased vulnerability to bacterial infections, particularly those caused by biofilm-forming pathogens. Traditional antibiotic treatments frequently fail against biofilms and contribute to the escalating problem of antibiotic resistance, emphasizing the need for alternative therapies that do not foster resistance. Photodynamic therapy (PDT), which uses light-activated photosensitizers to generate reactive oxygen species (ROS) for effective bacterial eradication, presents a promising noninvasive strategy with high precision and low likelihood of resistance development. This review thoroughly explores the mechanisms of PDT and its application to Ti implants, focusing on both organic and inorganic photosensitizers. Moreover, considering current challenges, the study investigates approaches to improve PDT’s effectiveness in combating implant-related infections. These include optimizing PDT systems, developing new AIE-active photosensitizers, increasing oxygen supply to boost ROS production, combining multi-modal antibacterial treatments, and designing dual-functional implants. The review aims to identify current limitations and propose future directions, offering valuable insights to advance PDT-based strategies that enhance the antibacterial performance of Ti implants in the post-antibiotic era.
| · | The inefficacy of antimicrobial action: Based on the principles of photodynamic reactions, the hypoxic microenvironment of biofilm infections and inadequate blood supply at implant sites frequently result in diminished oxygen levels, leading to an insufficient quantum yield of 1O₂ in type II PDT. The high recombination rate of photogenerated electron-hole pairs severely hampers ROS production efficiency in type I PDT. Furthermore, PDT alone often does not yield satisfactory therapeutic results. |
| · | The limited tissue penetration of exciting lights: Most organic and certain inorganic photosensitizers predominantly absorb lights with shorter wavelength, which inadequately penetrate tissue, hence restricting their application in the treatment of biofilm infections on Ti implants. |
| · | The intrinsic shortcomings of photosensitizers: Their comparatively feeble light absorption capacity culminates in suboptimal light consumption, resulting in energy wastage. Organic photosensitizers frequently encounter issues with physicochemical stability and photostability, whereas biocompatibility is a major limitation for inorganic photosensitizers. |
| · | Challenges in bone integration: The primary objective of infection management is to establish an optimal environment for osseointegration between Ti implants and host bone tissue. Nonetheless, the majority of current photosensitizers solely demonstrate the capacity to produce ROS upon light activation, devoid of advantageous bioactivities such as immunomodulation, angiogenesis, and osteogenesis that are vital for osseointegration. Consequently, additional modification of Ti implants is frequently necessary to enhance osteoconductivity and biocompatibility. |
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |